These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 32978971)

  • 1. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
    Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
    Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M
    Adv Rheumatol; 2020 Sep; 60(1):50. PubMed ID: 32962761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
    Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
    Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from dermatology about inflammatory responses in Covid-19.
    Criado PR; Pagliari C; Carneiro FRO; Quaresma JAS
    Rev Med Virol; 2020 Sep; 30(5):e2130. PubMed ID: 32656939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2.
    Breiman A; Ruvën-Clouet N; Le Pendu J
    PLoS Pathog; 2020 May; 16(5):e1008556. PubMed ID: 32437478
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 and interferon blockade.
    Diamond B; Volpe BT; VanPatten S; Al Abed Y
    Mol Med; 2020 Nov; 26(1):103. PubMed ID: 33167852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
    Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
    Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for targeting complement in COVID-19.
    Polycarpou A; Howard M; Farrar CA; Greenlaw R; Fanelli G; Wallis R; Klavinskis LS; Sacks S
    EMBO Mol Med; 2020 Aug; 12(8):e12642. PubMed ID: 32559343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
    Franco R; Rivas-Santisteban R; Serrano-Marín J; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G
    J Immunol; 2020 Sep; 205(5):1198-1206. PubMed ID: 32680957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and evasion of type I interferon responses by SARS-CoV-2.
    Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
    Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is SARS-CoV-2 infection milder among children?
    Palmeira P; Barbuto JAM; Silva CAA; Carneiro-Sampaio M
    Clinics (Sao Paulo); 2020; 75():e1947. PubMed ID: 32428111
    [No Abstract]   [Full Text] [Related]  

  • 20. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection.
    Meira E Cruz M; Miyazawa M; Gozal D
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32350105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.